The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Secondary prophylaxis with romiplostim for temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma.
 
Emilie Le Rhun
Honoraria - Mundipharma; Novartis
Consulting or Advisory Role - Abbvie; Daiichi Sankyo
Research Funding - Amgen (Inst); Mundipharma (Inst)
 
Patrick Devos
No Relationships to Disclose
 
Caroline Houillier
No Relationships to Disclose
 
Stéphanie Cartalat-Carel
No Relationships to Disclose
 
Olivier L. Chinot
Honoraria - Abbvie; Bristol-Myers Squibb; Immatics; IPSEN; SERVIER
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Roche
Research Funding - Roche
Patents, Royalties, Other Intellectual Property - Patent with aix Marseille University on the use of mmp as biomarkers to predict the benefit of anti angiogenic agents
Travel, Accommodations, Expenses - SERVIER
 
Anna Luisa Di Stefano
Consulting or Advisory Role - Abbvie
 
Malek Dib
No Relationships to Disclose
 
Nicolas Reyns
No Relationships to Disclose
 
François Dubois
No Relationships to Disclose
 
Michael Weller
Honoraria - Lilly; Merck Serono; MSD; Novocure; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celldex; Lilly; Merck Serono; Pfizer; Roche; Teva
Research Funding - Acceleron Pharma (Inst); Actelion (Inst); Bayer (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); OGD2 Pharma (Inst); Piqur (Inst); Roche (Inst); Tragara (Inst)